Azapride

Azapride is the azide derivative of the dopamine antagonist clebopride synthesized in order to label dopamine receptors.[1][2] It is an irreversible dopamine antagonist.[2]

Azapride

Clinical data
Other names	Azidoclebopride
ATC code	None
Identifiers
IUPAC name 4-Azido-5-chloro-2-methoxy-N-[1-(phenylmethyl)piperidin-4-yl]benzamide
CAS Number	92990-90-4
PubChem CID	3036441
ChemSpider	2300456
CompTox Dashboard (EPA)	DTXSID00239217
Chemical and physical data
Formula	C20H22ClN5O2
Molar mass	399.88 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Clc1cc(c(OC)cc1/N=[N+]=[N-])C(=O)NC3CCN(Cc2ccccc2)CC3
InChI InChI=1S/C20H22ClN5O2/c1-28-19-12-18(24-25-22)17(21)11-16(19)20(27)23-15-7-9-26(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13H2,1H3,(H,23,27) Key:CKKHIIXHAWWTNP-UHFFFAOYSA-N
(verify)

References

1. Niznik HB, Guan JH, Neumeyer JL, Seeman P (February 1985). "A photoaffinity ligand for dopamine D2 receptors: azidoclebopride". Molecular Pharmacology. 27 (2): 193–9. PMID 3969068.
2. Wouters W, Van Dun J, Laduron PM (December 1984). "Photoaffinity labelling of dopamine receptors. Synthesis and binding characteristics of azapride". European Journal of Biochemistry. 145 (2): 273–8. doi:10.1111/j.1432-1033.1984.tb08548.x. PMID 6548707.